Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

FSGS: Diagnosis and Diagnostic Work-Up.

Sprangers B, Meijers B, Appel G.

Biomed Res Int. 2016;2016:4632768. doi: 10.1155/2016/4632768. Epub 2016 May 24. Review.

2.

Pathogenesis of minimal change nephrotic syndrome: an immunological concept.

Kim SH, Park SJ, Han KH, Kronbichler A, Saleem MA, Oh J, Lim BJ, Shin JI.

Korean J Pediatr. 2016 May;59(5):205-11. doi: 10.3345/kjp.2016.59.5.205. Epub 2016 May 31. Review.

3.

TLR-mediated albuminuria needs TNFα-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice.

Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B, Panda S, Basak S, George A, Rath S, Bal V, Sopory S.

Dis Model Mech. 2016 Jun 1;9(6):707-17. doi: 10.1242/dmm.023440. Epub 2016 Apr 28.

4.

The podocyte as a direct target for treatment of glomerular disease?

Mallipattu SK, He JC.

Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F46-51. doi: 10.1152/ajprenal.00184.2016. Epub 2016 Apr 20.

PMID:
27097894
5.

Cell biology and genetics of minimal change disease.

Saleem MA, Kobayashi Y.

F1000Res. 2016 Mar 30;5. pii: F1000 Faculty Rev-412. doi: 10.12688/f1000research.7300.1. eCollection 2016. Review.

6.

Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis.

Sprenger-Mähr H, Zitt E, Soleiman A, Lhotta K.

Case Rep Transplant. 2016;2016:7137584. doi: 10.1155/2016/7137584. Epub 2016 Mar 20.

7.

The Players: Cells Involved in Glomerular Disease.

Kitching AR, Hutton HL.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1664-74. doi: 10.2215/CJN.13791215. Epub 2016 Apr 12.

PMID:
27073196
8.

Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.

Norlin J, Nielsen Fink L, Helding Kvist P, Douglas Galsgaard E, Coppieters K.

PLoS One. 2016 Apr 7;11(4):e0152315. doi: 10.1371/journal.pone.0152315. eCollection 2016.

9.

Update on the treatment of focal segmental glomerulosclerosis in renal transplantation.

Messina M, Gallo E, Mella A, Pagani F, Biancone L.

World J Transplant. 2016 Mar 24;6(1):54-68. doi: 10.5500/wjt.v6.i1.54. Review.

10.

Immunologic Changes Implicated in the Pathogenesis of Focal Segmental Glomerulosclerosis.

Kronbichler A, Leierer J, Oh J, Meijers B, Shin JI.

Biomed Res Int. 2016;2016:2150451. doi: 10.1155/2016/2150451. Epub 2016 Feb 17. Review.

11.

Podocytes.

Reiser J, Altintas MM.

F1000Res. 2016 Jan 28;5. pii: F1000 Faculty Rev-114. doi: 10.12688/f1000research.7255.1. eCollection 2016. Review.

12.

Cyclin-dependent kinase 2 protects podocytes from apoptosis.

Saurus P, Kuusela S, Dumont V, Lehtonen E, Fogarty CL, Lassenius MI, Forsblom C, Lehto M, Saleem MA, Groop PH, Lehtonen S.

Sci Rep. 2016 Feb 15;6:21664. doi: 10.1038/srep21664.

13.

Human genetics of nephrotic syndrome and the quest for precision medicine.

Greka A.

Curr Opin Nephrol Hypertens. 2016 Mar;25(2):138-43. doi: 10.1097/MNH.0000000000000204.

PMID:
26808706
14.

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.

J Am Soc Nephrol. 2016 Aug;27(8):2520-7. doi: 10.1681/ASN.2015091002. Epub 2015 Dec 23.

PMID:
26701979
15.

A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues.

Wada T, Nangaku M.

Clin Kidney J. 2015 Dec;8(6):708-15. doi: 10.1093/ckj/sfv090. Epub 2015 Sep 15. Review.

16.

What is damaging the kidney in lupus nephritis?

Davidson A.

Nat Rev Rheumatol. 2016 Mar;12(3):143-53. doi: 10.1038/nrrheum.2015.159. Epub 2015 Nov 19. Review.

PMID:
26581344
17.

Nonimmunologic targets of immunosuppressive agents in podocytes.

Yoo TH, Fornoni A.

Kidney Res Clin Pract. 2015 Jun;34(2):69-75. doi: 10.1016/j.krcp.2015.03.003. Epub 2015 Apr 9. Review.

18.

DC-SIGN expression on podocytes and its role in inflammatory immune response of lupus nephritis.

Cai M, Zhou T, Wang X, Shang M, Zhang Y, Luo M, Xu C, Yuan W.

Clin Exp Immunol. 2016 Mar;183(3):317-25. doi: 10.1111/cei.12723. Epub 2015 Nov 24.

PMID:
26440060
19.

A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome.

Bonanni A, Bertelli R, Rossi R, Bruschi M, Di Donato A, Ravani P, Ghiggeri GM.

PLoS One. 2015 Sep 28;10(9):e0138343. doi: 10.1371/journal.pone.0138343. eCollection 2015.

20.

CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.

Bassi R, Fornoni A, Doria A, Fiorina P.

Diabetologia. 2016 Jan;59(1):21-9. doi: 10.1007/s00125-015-3766-6. Epub 2015 Sep 26.

PMID:
26409459
Items per page

Supplemental Content

Write to the Help Desk